William Blair Has Negative Estimate for JSPR Q2 Earnings

Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Equities research analysts at William Blair lowered their Q2 2025 EPS estimates for Jasper Therapeutics in a report released on Tuesday, May 13th. William Blair analyst M. Phipps now expects that the com…

Read Full Article →